May 20, 2020 - Discoveries

Using the immune response to develop coronavirus treatments and vaccines

Dennis Burton, PhD, and Thomas Rogers, MD, PhD, are studying the human immune response to SARS-CoV-2 infections and working to identify antibodies that may serve as the basis for vaccines or antiviral therapies. They need volunteers who have recovered from COVID-19 to help with their research. If you are interested in helping, contact Karen Westfall at kwestfall@scripps.edu.

Explore related news

02/23/2021

Important research antibodies get their close-up

Read more

02/03/2021

First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research

Read more

12/23/2020

How Scripps Research helped map the course for today’s COVID-19 vaccines

Read more

11/20/2020

Scripps Research scientists capture 15 spots on ranking of most highly cited researchers

Read more

11/18/2020

Engineered immune cells elicit broad response to HIV in mice, offering hope for vaccine or functional cure

Read more

10/26/2020

Antibodies co-invented by Scripps Research and IAVI to be developed as a potential COVID-19 therapy

Read more

10/23/2020

New imaging method reveals HIV’s sugary shield in unprecedented detail

Read more

09/21/2020

Nanoparticle vaccine for COVID-19 spurs robust immune response in preclinical tests

Read more